Conduit Pharmaceuticals
CDT • NASDAQ
Conduit Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrew Regan, with a market cap of $27.8M.
Market Cap$27.8M
Employees7.0
CEOAndrew Regan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
CDT
Conduit Pharmaceuticals FAQ
Common questions about Conduit Pharmaceuticals
Conduit Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 14, 2026.
Conduit Pharmaceuticals has approximately 7 employees.